Mirum Pharmaceuticals (MIRM) Research & Development (2020 - 2025)
Historic Research & Development for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Q3 2025 value amounting to $43.0 million.
- Mirum Pharmaceuticals' Research & Development rose 3547.78% to $43.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $179.1 million, marking a year-over-year increase of 4042.53%. This contributed to the annual value of $140.6 million for FY2024, which is 3705.43% up from last year.
- Latest data reveals that Mirum Pharmaceuticals reported Research & Development of $43.0 million as of Q3 2025, which was up 3547.78% from $46.1 million recorded in Q2 2025.
- In the past 5 years, Mirum Pharmaceuticals' Research & Development ranged from a high of $46.1 million in Q2 2025 and a low of $22.0 million during Q2 2023
- Its 5-year average for Research & Development is $32.5 million, with a median of $31.1 million in 2022.
- Per our database at Business Quant, Mirum Pharmaceuticals' Research & Development soared by 11991.93% in 2021 and then crashed by 3683.33% in 2022.
- Quarter analysis of 5 years shows Mirum Pharmaceuticals' Research & Development stood at $27.8 million in 2021, then rose by 11.99% to $31.1 million in 2022, then fell by 0.55% to $30.9 million in 2023, then soared by 42.32% to $44.0 million in 2024, then fell by 2.42% to $43.0 million in 2025.
- Its Research & Development stands at $43.0 million for Q3 2025, versus $46.1 million for Q2 2025 and $46.0 million for Q1 2025.